XLA and Recurrent Conjunctivitis: a Unique Association?
Journal of Clinical Immunology · 2023-04 · 43 (3) · 548-549
DOI: 10.1007/s10875-022-01424-0 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Immunology, online erschienen am 23.12.2022. Verfasst von Vyanka Redenbaugh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland. Vyanka.redenbaugh@gmail.com. Hauptthemen laut MEDLINE: Conjunctivitis, Agammaglobulinemia, Genetic Diseases, X-Linked. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland. Vyanka.redenbaugh@gmail.com.
- Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA. Vyanka.redenbaugh@gmail.com.
- St James's Hospital, Dublin 8, Republic of Ireland.
- Trinity College Dublin, Dublin, Republic of Ireland.
- Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland.
ORCID-Profile: Vyanka Redenbaugh
Zitieren
APA
Redenbaugh, V., Sloan, A., Sui, J., Edgar, J. D., & Coulter, T. (2023). XLA and Recurrent Conjunctivitis: a Unique Association?. Journal of Clinical Immunology, 43(3), 548-549. https://doi.org/10.1007/s10875-022-01424-0
Vancouver
Redenbaugh V, Sloan A, Sui J, Edgar JD, Coulter T. XLA and Recurrent Conjunctivitis: a Unique Association?. Journal of Clinical Immunology. 2023;43(3):548-549. doi:10.1007/s10875-022-01424-0
BibTeX
@article{Redenbaugh2023,
author = {Redenbaugh, Vyanka and Sloan, Anne and Sui, Jacklyn and Edgar, John David and Coulter, Tanya},
title = {XLA and Recurrent Conjunctivitis: a Unique Association?},
journal = {Journal of Clinical Immunology},
year = {2023},
volume = {43},
number = {3},
pages = {548--549},
doi = {10.1007/s10875-022-01424-0}
}
EUVIMED